» Articles » PMID: 34227914

COVID-19 Vaccine Hesitancy in Zambia: a Glimpse at the Possible Challenges Ahead for COVID-19 Vaccination Rollout in Sub-Saharan Africa

Abstract

With unprecedented speed, multiple vaccines against SARS-CoV-2 are available 1 year after the COVID-19 pandemic was first identified. As we push to achieve global control through these new vaccines, old challenges present themselves, including cold-chain storage, the logistics of mass vaccination, and vaccine hesitancy. Understanding how much hesitancy toward COVID-19 vaccines might occur and what factors may be driving these concerns can improve the ability of public health workers and communicators to maximize vaccine uptake. We nested a survey within a measles-rubella mass vaccination campaign in Zambia in November 2020 and asked about sentiments and beliefs toward COVID-19 and COVID-19 vaccines. Among parents bringing their children to receive a measles-rubella vaccine, we found high acceptability of COVID-19 vaccination of their children, but substantial uncertainty and hesitancy about receiving the vaccine themselves. COVID-19 vaccination hesitancy was correlated with beliefs around COVID-19 severity and risk, as well as vaccine safety and effectiveness.

Citing Articles

Perceptions and predictors of COVID-19 vaccine hesitancy among healthcare providers across five countries in sub-Saharan Africa.

Madzorera I, Abokyi L, Apraku E, Azemraw T, Boudo V, James C PLOS Glob Public Health. 2025; 5(2):e0003956.

PMID: 39982973 PMC: 11844854. DOI: 10.1371/journal.pgph.0003956.


A scoping review of COVID-19 vaccine hesitancy: refusal rate, associated factors, and strategies to reduce.

Bahreini R, Sardareh M, Arab-Zozani M Front Public Health. 2024; 12:1382849.

PMID: 39473604 PMC: 11518786. DOI: 10.3389/fpubh.2024.1382849.


Vaccine hesitancy in context of COVID-19 in East Africa: systematic review and meta-analysis.

Alie M, Abebe G, Negesse Y, Adugna A, Girma D BMC Public Health. 2024; 24(1):2796.

PMID: 39395943 PMC: 11470748. DOI: 10.1186/s12889-024-20324-z.


[Refusal and hesitation regarding vaccination against COVID-19 in Douala, Cameroon].

Bita Fouda A, Kengne V, Adiogo D, Manga L Pan Afr Med J. 2024; 48:61.

PMID: 39355714 PMC: 11444086. DOI: 10.11604/pamj.2024.48.61.39880.


Motivation, Cues to Action, and Barriers to COVID-19 Vaccine Uptake: A Qualitative Application of the Health Belief Model among Women in Rural Zambia.

Kuhfeldt K, Kaiser J, Morgan A, Ngoma T, Hamer D, Fink G Am J Trop Med Hyg. 2024; 111(5):1118-1126.

PMID: 39191235 PMC: 11542508. DOI: 10.4269/ajtmh.24-0005.


References
1.
Sauer M, Vasudevan P, Meghani A, Luthra K, Garcia C, Knoll M . Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries. Vaccine. 2021; 39(11):1556-1564. PMC: 7960636. DOI: 10.1016/j.vaccine.2021.01.066. View

2.
Fisher K, Bloomstone S, Walder J, Crawford S, Fouayzi H, Mazor K . Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults. Ann Intern Med. 2020; 173(12):964-973. PMC: 7505019. DOI: 10.7326/M20-3569. View

3.
Malik A, McFadden S, Elharake J, Omer S . Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020; 26:100495. PMC: 7423333. DOI: 10.1016/j.eclinm.2020.100495. View

4.
Lazarus J, Ratzan S, Palayew A, Gostin L, Larson H, Rabin K . A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2020; 27(2):225-228. PMC: 7573523. DOI: 10.1038/s41591-020-1124-9. View

5.
Karlsson L, Soveri A, Lewandowsky S, Karlsson L, Karlsson H, Nolvi S . Fearing the disease or the vaccine: The case of COVID-19. Pers Individ Dif. 2021; 172:110590. PMC: 7832025. DOI: 10.1016/j.paid.2020.110590. View